{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:33:25Z","timestamp":1791221605476,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T00:00:00Z","timestamp":1318809600000},"content-version":"vor","delay-in-days":46,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:p>Fertmann JM, Arbogast HP, Illner W\u2010D, Tarabichi A, Dieterle C, Land W, Jauch K\u2010W, Hoffmann JN. Antithrombin therapy in pancreas retransplantation and pancreas\u2010after\u2010kidney\/pancreas\u2010transplantation\u2010alone patients.\u2028Clin Transplant 2011: 25: E499\u2013E508. \u00a9 2011 John Wiley &amp; Sons A\/S.<\/jats:p><jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Antithrombin (AT) is a coagulatory inhibitor with pleiotropic activities. AT reduces ischemia\/reperfusion injury and has been successfully used in patients with simultaneous pancreas kidney transplantation. This study retrospectively analyzes prophylactic high\u2010dose AT application in patients with solitary pancreas transplantation traditionally related to suboptimal results. In our center, 31 patients received solitary pancreas transplantation between 7\/1994 and 7\/2005 (pancreas retransplantation, PAK\/PTA). The perioperative treatment protocol was modified in 5\/2002 now including application of 3000\u2003IU. AT was given intravenously before pancreatic reperfusion (AT, n\u2003=\u200318). Patients receiving standard therapy served as controls (n\u2003=\u200313). Daily blood sampling was performed during five postoperative days. Standard coagulatory parameters and number of transfused red blood cell units were not altered by AT. In AT patients serum amylase (p\u2003&lt;\u20030.01) and lipase (p\u2003&lt;\u20030.01) on postoperative days\u20031, 2 and 3 were significantly reduced. Our actual perioperative management protocol including high dose AT application in human solitary pancreas transplantation reduced postoperative liberation of pancreatic enzymes in this pilot study. Prophylactic AT application should deserve further clinical testing in a randomized controlled trial.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2011.01472.x","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T05:01:31Z","timestamp":1318827691000},"source":"Crossref","is-referenced-by-count":12,"title":["Antithrombin therapy in pancreas retransplantation and pancreas\u2010after\u2010kidney\/pancreas\u2010transplantation\u2010alone patients"],"prefix":"10.1111","volume":"25","author":[{"given":"Jan M.","family":"Fertmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut P.","family":"Arbogast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf\u2010Dieter","family":"Illner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Tarabichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Dieterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl\u2010Walter","family":"Jauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes N.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,10,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(99)00135-0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2003.09.013"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-200405000-00010"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.12.003"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2005.00378.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(03)00439-1"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(01)00895-X"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2004.00183.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00663.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000139691.54108.1F"},{"key":"e_1_2_6_12_2","first-page":"195","article-title":"Antithrombin III reduces renal ischemia\u2010reperfusion injury in rats","volume":"200","author":"\u00d6Zden A","year":"2001","journal-title":"Res Exp Med"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.7.2302"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.1.157"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80213-2"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2004.03.017"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2002.20605.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000041781.94679.A1"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2006.00325.x"},{"key":"e_1_2_6_20_2","first-page":"394","article-title":"High dose antithrombin therapy reduces ischemia\/reperfusion injury during human allogenic kidney transplantation: first results of a randomized controlled trial","volume":"74","author":"Hoffmann JN","year":"2002","journal-title":"Transplantation"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199808000-00002"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199711000-00003"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH05-07-0530"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-0037-1613194","article-title":"Adverse effects of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms","volume":"88","author":"Hoffmann JN","year":"2002","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200008000-00032"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200205001-00024"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1160\/TH06-02-0118","article-title":"Antithrombin is as effective as heparin and hirudin to prevent formation of microvascular thrombosis in a murine model","volume":"96","author":"Sorg H","year":"2006","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc3758"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1078"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199911150-00020"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703335"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000137198.09182.A2"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.04.051"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2011.01472.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2011.01472.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:33:51Z","timestamp":1697405631000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2011.01472.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1111\/j.1399-0012.2011.01472.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2011.01472.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}